Cardiovascular Disease Shouldn't Go Undetected For Women. More Accurate Solutions For Life-Saving Care.

Coronary Artery Disease Diagnosed And Treated - Now With Confidence.

Lupus Nephritis Can Be Devastating. LUPKYNIS™ - Reducing The Need For Kidney Transplants.

Robotic Joint Replacement Surgery - Less Invasive, Highly Successful.

Disruptive Cancer Therapies - Made To Make A Difference.

Active Epileptic Seizures Can Now Be Terminated On Demand.

Chemotherapy Without Destroying Your Immune System? COSELA® (trilaciclib) Has It Conquered.

No Longer A Chronic Life-Long Disease - Hepatitis C Cured.

Proactive Care, Heartfelt Impact— Advancing Heart Failure Management at Home.

Performance is More Than Just Great Returns To Our Investors. It Is Also Measured By Impact.

Venture capital Canada
40+ Diseases Targeted
Lumira Biotech Venture Capital Firm Canada
35+ Approved Products
Ontario Venture Capital
$75+ Billion Cumulative Revenue from Approved Products
Lumira Capital Venture Capital in Canada
Over 5 Million Patients Treated
Venture Capital Life Sciences
$6+ Billion Capital Raised by Portfolio Companies
Scroll to Top